The Turkish experience of COVID-19 infection in people with NMOSD and MOGAD: A milder course?

Author
YÜCEYAR, AYŞE NUR
GÜMÜŞ, HALUK
Arslan, Gokhan
Kilic, Ahmet Kasim
Altintas, Ayse
TURAN, ÖMER FARUK
Tutuncu, Melih
TERZİ, MURAT
Acar, Pinar
BÜNÜL, SENA DESTAN
Balci, Belgin Petek
BİR, LEVENT SİNAN
Koseoglu, Mesrure
Mungan, Semra
Gunduz, Tuncay
Dogan, Ipek Gungor
Kotan, Dilcan
Uygunoglu, Ugur
EKMEKCİ, ÖZGÜL
DEMİRKIRAN, DURUHAN MELTEM
KAMIŞLI, ÖZDEN
CANBAZ KABAY, SİBEL
Tamam, Yusuf
Omerhoca, Sami
Sevim, Serhan
Guler, Sibel
Kurtuncu, Murat
EFENDİ, HÜSNÜ
KARABUDAK, RANA
SİVA, AKSEL
Sen, Sedat
Tuncer, Asli
ÖZAKBAŞ, SERKAN
Uzunkopru, Cihat
Baba, Cavid
Demir, Serkan
BECKMANN, YEŞİM
Metadata
Show full item record
Abstract
Background: COVID-19 is a multisystemic infection with variables consequences depending on individual and comorbid conditions. The course and outcomes of COVID-19 during neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) are not clearly known.
URI
http://hdl.handle.net/20.500.12627/182502
https://doi.org/10.1016/j.msard.2021.103399
Collections